1. Calycosin-7-O-β-D-glucoside Attenuates OGD/R-Induced Damage by Preventing Oxidative Stress and Neuronal Apoptosis via the SIRT1/FOXO1/PGC-1α Pathway in HT22 Cells. (1st December 2019) Authors: Yan, Xiangli; Yu, Aiming; Zheng, Haozhen; Wang, Shengxin; He, Yingying; Wang, Lisheng Other Names: Kossut Malgorzata Academic Editor. Journal: Neural plasticity Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cell Chromatography-Based Screening of the Active Components in Buyang Huanwu Decoction Promoting Axonal Regeneration. (29th September 2019) Authors: Yan, Xiangli; Wang, Shengxin; Yu, Aiming; Shen, Xiao; Zheng, Haozhen; Wang, Lisheng Other Names: Xu Gelin Academic Editor. Journal: BioMed research international Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effects of carnitine palmitoyltransferases on cancer cellular senescence. Issue 2 (2nd August 2018) Authors: Guan, Lihuan; Chen, Yixin; Wang, Yongtao; Zhang, Huizhen; Fan, Shicheng; Gao, Yue; Jiao, Tingying; Fu, Kaili; Sun, Jiahong; Yu, Aiming; Huang, Min; Bi, Huichang Journal: Journal of cellular physiology Issue: Volume 234:Issue 2(2019:Feb.) Page Start: 1707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Erythrocyte membrane affinity chromatography, solid-phase extraction and UPLC-QTOF-MS/MS to screen active ingredients of Buyang Huanwu decoction. Issue 50 (17th September 2019) Authors: Yu, Aiming; Zheng, Huazhu; Yan, Xiangli; Wang, Shengxin; Shen, Xiao; Zheng, Haozhen; Meng, Yingjiao; Wang, Lisheng Journal: RSC advances Issue: Volume 9:Issue 50(2019) Page Start: 29217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD07-02 TARGETING WNT5A/FZD2 SIGNALING OVERCOMES RESISTANCE TO ENZALUTAMIDE IN ADVANCED PROSTATE CANCER. (May 2022) Authors: Ning, Shu; Liu, Chengfei; Lou, Wei; Lombard, Alan; D'Abronzo, Leandro; Yu, Aiming; Evans, Christopher; Gao, Allen Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non–Small-Cell Lung Cancer. (2021) Authors: McCoach, Caroline E.; Yu, Aiming; Gandara, David R.; Riess, Jonathan W.; Vang, Daniel P.; Li, Tiahong; Lara, Primo N.; Gubens, Matthew; Lara, Frances; Mack, Philip C.; Beckett, Laurel A.; Kelly, Karen Journal: JCO precision oncology Issue: Volume 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET‐Positive Non‐Small‐Cell Lung Cancer. (December 2021) Authors: McCoach, Caroline E.; Yu, Aiming; Gandara, David R.; Riess, Jonathan W.; Vang, Daniel P.; Li, Tiahong; Lara, Primo N.; Gubens, Matthew; Lara, Frances; Mack, Philip C.; Beckett, Laurel A.; Kelly, Karen Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Potential role of CYP2D6 in the central nervous system. (November 2013) Authors: Cheng, Jie; Zhen, Yueying; Miksys, Sharon; Beyoğlu, Diren; Krausz, Kristopher W.; Tyndale, Rachel F.; Yu, Aiming; Idle, Jeffrey R.; Gonzalez, Frank J. Journal: Xenobiotica Issue: Volume 43:Number 11(2013:Nov.) Page Start: 973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗